Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125280502 | 12528050 | 2 | F | 20160819 | 20160705 | 20160825 | EXP | DE-PFIZER INC-2016329176 | PFIZER | ZEEH, J.. SEVEN STEPS FOR DRUG REDUCTION. ADVANCES IN MEDICINE. 2016;158 (11):54-57 | 88.00 | YR | F | Y | 49.00000 | KG | 20160825 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125280502 | 12528050 | 1 | SS | CANDESARTAN CILEXETIL. | CANDESARTAN CILEXETIL | 1 | Oral | 16 MG, 1X/DAY | Y | 0 | 16 | MG | TABLET | QD | |||||
| 125280502 | 12528050 | 2 | SS | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, 1X/DAY | Y | 0 | 20 | MG | QD | ||||||
| 125280502 | 12528050 | 3 | SS | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | UNK (2 WEEKS AT HALF-DOSAGE) | Y | 0 | ||||||||||
| 125280502 | 12528050 | 4 | SS | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 1 MG, 1X/DAY | Y | 0 | 1 | MG | TABLET | QD | |||||
| 125280502 | 12528050 | 5 | SS | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 850 MG, 2X/DAY | Y | 0 | 850 | MG | BID | ||||||
| 125280502 | 12528050 | 6 | PS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 5 MG, 2X/DAY | Y | 19901 | 5 | MG | BID | ||||||
| 125280502 | 12528050 | 7 | SS | RAMIPRIL. | RAMIPRIL | 1 | UNK (IN 1/2 DOSAGE) | Y | 19901 | ||||||||||
| 125280502 | 12528050 | 8 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | Y | 0 | 300 | MG | QD | ||||||
| 125280502 | 12528050 | 9 | SS | DIGITOXIN | DIGITOXIN | 1 | 0.07 MG, 1X/DAY | Y | 0 | .07 | MG | QD | |||||||
| 125280502 | 12528050 | 10 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, 2X/DAY | Y | 0 | 40 | MG | BID | ||||||
| 125280502 | 12528050 | 11 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | UNK (AT HALF DOSAGE) | Y | 0 | ||||||||||
| 125280502 | 12528050 | 12 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, 1X/DAY | Y | 0 | 25 | MG | QD | ||||||
| 125280502 | 12528050 | 13 | SS | INSULIN | INSULIN NOS | 1 | Unknown | 30/70 IU, 26-0-16 (CONTINUE BUT ADJUST THE DOSE) | 0 | ||||||||||
| 125280502 | 12528050 | 14 | SS | ISOSORBIDE DINITRATE. | ISOSORBIDE DINITRATE | 1 | Oral | 20 MG, 2X/DAY (TAPER THE DRUG WITHIN A WEEK) | Y | 0 | 20 | MG | BID | ||||||
| 125280502 | 12528050 | 15 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 47.5 MG, 2X/DAY | Y | 0 | 47.5 | MG | BID | ||||||
| 125280502 | 12528050 | 16 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK (AT HALF DOSAGE) | Y | 0 | ||||||||||
| 125280502 | 12528050 | 17 | SS | MOXONIDINE | MOXONIDINE | 1 | Oral | 0.4 MG, 1X/DAY (TAPER OVER ONE WEEK) | Y | 0 | .4 | MG | QD | ||||||
| 125280502 | 12528050 | 18 | SS | Tilidin | NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE | 1 | Oral | 1 DF, 3X/DAY (50/4MG) | Y | 0 | 1 | DF | TID | ||||||
| 125280502 | 12528050 | 19 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY (2 WEEKS AT HALF-DOSAGE, THEN STOP) | Y | 0 | 40 | MG | QD | ||||||
| 125280502 | 12528050 | 20 | SS | TROSPIUM | TROSPIUM | 1 | Oral | 15 MG, 1X/DAY | Y | 0 | 15 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125280502 | 12528050 | 8 | Blood uric acid increased |
| 125280502 | 12528050 | 13 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125280502 | 12528050 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125280502 | 12528050 | Asthenia | |
| 125280502 | 12528050 | Decreased appetite | |
| 125280502 | 12528050 | General physical health deterioration | |
| 125280502 | 12528050 | Hypotension | |
| 125280502 | 12528050 | Somnolence | |
| 125280502 | 12528050 | Urinary incontinence | |
| 125280502 | 12528050 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |